Advertisement
Screener

INTEGRATED BIOPHARMA INC (INBP) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

2.0 / 5 stars · 47/116 Roast Me

INTEGRATED BIOPHARMA INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate

INTEGRATED BIOPHARMA INC (INBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 131.70% for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2024-11-13

  • INTEGRATED BIOPHARMA INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-09-30 was 131.70%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month
2024-09-30131.70%
10-Q · filed 2024-11-13